世界の先天性心疾患市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Congenital Heart Disease Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1537
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、133ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、先天性心疾患のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬品、手術療法）、用途別市場規模（病院・クリニック、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・先天性心疾患の市場動向
・企業の競争状況、市場シェア
・先天性心疾患の種類別市場規模（薬品、手術療法）
・先天性心疾患の用途別市場規模（病院・クリニック、診断センター）
・先天性心疾患の北米市場規模2016-2027（アメリカ、カナダ）
・先天性心疾患のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・先天性心疾患のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・先天性心疾患の中南米市場規模2016-2027（メキシコ、ブラジル）
・先天性心疾患の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Novartis、Abbott Laboratories、Roche、GSK、Sanofi、Johnson & Johnson、Medtronic、BD、Boston Scientific、Merck、Eli Lilly、Mylan、Sun Pharmaceutical、AstraZeneca）
・結論

Market Analysis and Insights: Global Congenital Heart Disease Market
The global Congenital Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Congenital Heart Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Congenital Heart Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Congenital Heart Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Congenital Heart Disease market.

Global Congenital Heart Disease Scope and Market Size
Congenital Heart Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Congenital Heart Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medication
Surgical Therapy

Segment by Application
Hospitals and clinics
Diagnostic centres

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
Abbott Laboratories
Roche
GSK
Sanofi
Johnson & Johnson
Medtronic
BD
Roche
GSK
Eli Lilly
Mylan

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Congenital Heart Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Surgical Therapy
1.3 Market by Application
1.3.1 Global Congenital Heart Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and clinics
1.3.3 Diagnostic centres
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Congenital Heart Disease Market Perspective (2016-2027)
2.2 Congenital Heart Disease Growth Trends by Regions
2.2.1 Congenital Heart Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Congenital Heart Disease Historic Market Share by Regions (2016-2021)
2.2.3 Congenital Heart Disease Forecasted Market Size by Regions (2022-2027)
2.3 Congenital Heart Disease Industry Dynamic
2.3.1 Congenital Heart Disease Market Trends
2.3.2 Congenital Heart Disease Market Drivers
2.3.3 Congenital Heart Disease Market Challenges
2.3.4 Congenital Heart Disease Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Congenital Heart Disease Players by Revenue
3.1.1 Global Top Congenital Heart Disease Players by Revenue (2016-2021)
3.1.2 Global Congenital Heart Disease Revenue Market Share by Players (2016-2021)
3.2 Global Congenital Heart Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Congenital Heart Disease Revenue
3.4 Global Congenital Heart Disease Market Concentration Ratio
3.4.1 Global Congenital Heart Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Congenital Heart Disease Revenue in 2020
3.5 Congenital Heart Disease Key Players Head office and Area Served
3.6 Key Players Congenital Heart Disease Product Solution and Service
3.7 Date of Enter into Congenital Heart Disease Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Congenital Heart Disease Breakdown Data by Type
4.1 Global Congenital Heart Disease Historic Market Size by Type (2016-2021)
4.2 Global Congenital Heart Disease Forecasted Market Size by Type (2022-2027)

5 Congenital Heart Disease Breakdown Data by Application
5.1 Global Congenital Heart Disease Historic Market Size by Application (2016-2021)
5.2 Global Congenital Heart Disease Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Congenital Heart Disease Market Size (2016-2027)
6.2 North America Congenital Heart Disease Market Size by Type
6.2.1 North America Congenital Heart Disease Market Size by Type (2016-2021)
6.2.2 North America Congenital Heart Disease Market Size by Type (2022-2027)
6.2.3 North America Congenital Heart Disease Market Size by Type (2016-2027)
6.3 North America Congenital Heart Disease Market Size by Application
6.3.1 North America Congenital Heart Disease Market Size by Application (2016-2021)
6.3.2 North America Congenital Heart Disease Market Size by Application (2022-2027)
6.3.3 North America Congenital Heart Disease Market Size by Application (2016-2027)
6.4 North America Congenital Heart Disease Market Size by Country
6.4.1 North America Congenital Heart Disease Market Size by Country (2016-2021)
6.4.2 North America Congenital Heart Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Congenital Heart Disease Market Size (2016-2027)
7.2 Europe Congenital Heart Disease Market Size by Type
7.2.1 Europe Congenital Heart Disease Market Size by Type (2016-2021)
7.2.2 Europe Congenital Heart Disease Market Size by Type (2022-2027)
7.2.3 Europe Congenital Heart Disease Market Size by Type (2016-2027)
7.3 Europe Congenital Heart Disease Market Size by Application
7.3.1 Europe Congenital Heart Disease Market Size by Application (2016-2021)
7.3.2 Europe Congenital Heart Disease Market Size by Application (2022-2027)
7.3.3 Europe Congenital Heart Disease Market Size by Application (2016-2027)
7.4 Europe Congenital Heart Disease Market Size by Country
7.4.1 Europe Congenital Heart Disease Market Size by Country (2016-2021)
7.4.2 Europe Congenital Heart Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Congenital Heart Disease Market Size (2016-2027)
8.2 Asia-Pacific Congenital Heart Disease Market Size by Type
8.2.1 Asia-Pacific Congenital Heart Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Congenital Heart Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Congenital Heart Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Congenital Heart Disease Market Size by Application
8.3.1 Asia-Pacific Congenital Heart Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Congenital Heart Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Congenital Heart Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Congenital Heart Disease Market Size by Region
8.4.1 Asia-Pacific Congenital Heart Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Congenital Heart Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Congenital Heart Disease Market Size (2016-2027)
9.2 Latin America Congenital Heart Disease Market Size by Type
9.2.1 Latin America Congenital Heart Disease Market Size by Type (2016-2021)
9.2.2 Latin America Congenital Heart Disease Market Size by Type (2022-2027)
9.2.3 Latin America Congenital Heart Disease Market Size by Type (2016-2027)
9.3 Latin America Congenital Heart Disease Market Size by Application
9.3.1 Latin America Congenital Heart Disease Market Size by Application (2016-2021)
9.3.2 Latin America Congenital Heart Disease Market Size by Application (2022-2027)
9.3.3 Latin America Congenital Heart Disease Market Size by Application (2016-2027)
9.4 Latin America Congenital Heart Disease Market Size by Country
9.4.1 Latin America Congenital Heart Disease Market Size by Country (2016-2021)
9.4.2 Latin America Congenital Heart Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Congenital Heart Disease Market Size (2016-2027)
10.2 Middle East & Africa Congenital Heart Disease Market Size by Type
10.2.1 Middle East & Africa Congenital Heart Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Congenital Heart Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Congenital Heart Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Congenital Heart Disease Market Size by Application
10.3.1 Middle East & Africa Congenital Heart Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Congenital Heart Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Congenital Heart Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Congenital Heart Disease Market Size by Country
10.4.1 Middle East & Africa Congenital Heart Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Congenital Heart Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Congenital Heart Disease Introduction
11.1.4 Pfizer Revenue in Congenital Heart Disease Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Congenital Heart Disease Introduction
11.2.4 Novartis Revenue in Congenital Heart Disease Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Congenital Heart Disease Introduction
11.3.4 Abbott Laboratories Revenue in Congenital Heart Disease Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Congenital Heart Disease Introduction
11.4.4 Roche Revenue in Congenital Heart Disease Business (2016-2021)
11.4.5 Roche Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Congenital Heart Disease Introduction
11.5.4 GSK Revenue in Congenital Heart Disease Business (2016-2021)
11.5.5 GSK Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Congenital Heart Disease Introduction
11.6.4 Sanofi Revenue in Congenital Heart Disease Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Congenital Heart Disease Introduction
11.7.4 Johnson & Johnson Revenue in Congenital Heart Disease Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Medtronic
11.8.1 Medtronic Company Details
11.8.2 Medtronic Business Overview
11.8.3 Medtronic Congenital Heart Disease Introduction
11.8.4 Medtronic Revenue in Congenital Heart Disease Business (2016-2021)
11.8.5 Medtronic Recent Development
11.9 BD
11.9.1 BD Company Details
11.9.2 BD Business Overview
11.9.3 BD Congenital Heart Disease Introduction
11.9.4 BD Revenue in Congenital Heart Disease Business (2016-2021)
11.9.5 BD Recent Development
11.10 Boston Scientific
11.10.1 Boston Scientific Company Details
11.10.2 Boston Scientific Business Overview
11.10.3 Boston Scientific Congenital Heart Disease Introduction
11.10.4 Boston Scientific Revenue in Congenital Heart Disease Business (2016-2021)
11.10.5 Boston Scientific Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Congenital Heart Disease Introduction
11.11.4 Merck Revenue in Congenital Heart Disease Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Congenital Heart Disease Introduction
11.12.4 Eli Lilly Revenue in Congenital Heart Disease Business (2016-2021)
11.12.5 Eli Lilly Recent Development
11.13 Mylan
11.13.1 Mylan Company Details
11.13.2 Mylan Business Overview
11.13.3 Mylan Congenital Heart Disease Introduction
11.13.4 Mylan Revenue in Congenital Heart Disease Business (2016-2021)
11.13.5 Mylan Recent Development
11.14 Sun Pharmaceutical
11.14.1 Sun Pharmaceutical Company Details
11.14.2 Sun Pharmaceutical Business Overview
11.14.3 Sun Pharmaceutical Congenital Heart Disease Introduction
11.14.4 Sun Pharmaceutical Revenue in Congenital Heart Disease Business (2016-2021)
11.14.5 Sun Pharmaceutical Recent Development
11.15 AstraZeneca
11.15.1 AstraZeneca Company Details
11.15.2 AstraZeneca Business Overview
11.15.3 AstraZeneca Congenital Heart Disease Introduction
11.15.4 AstraZeneca Revenue in Congenital Heart Disease Business (2016-2021)
11.15.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Congenital Heart Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Surgical Therapy
Table 4. Global Congenital Heart Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Congenital Heart Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Congenital Heart Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Congenital Heart Disease Market Share by Regions (2016-2021)
Table 8. Global Congenital Heart Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Congenital Heart Disease Market Share by Regions (2022-2027)
Table 10. Congenital Heart Disease Market Trends
Table 11. Congenital Heart Disease Market Drivers
Table 12. Congenital Heart Disease Market Challenges
Table 13. Congenital Heart Disease Market Restraints
Table 14. Global Congenital Heart Disease Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Congenital Heart Disease Market Share by Players (2016-2021)
Table 16. Global Top Congenital Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congenital Heart Disease as of 2020)
Table 17. Ranking of Global Top Congenital Heart Disease Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Congenital Heart Disease Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Congenital Heart Disease Product Solution and Service
Table 21. Date of Enter into Congenital Heart Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Congenital Heart Disease Revenue Market Share by Type (2016-2021)
Table 25. Global Congenital Heart Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Congenital Heart Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Congenital Heart Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Congenital Heart Disease Revenue Market Share by Application (2016-2021)
Table 29. Global Congenital Heart Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Congenital Heart Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Congenital Heart Disease Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Congenital Heart Disease Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Congenital Heart Disease Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Congenital Heart Disease Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Congenital Heart Disease Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Congenital Heart Disease Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Congenital Heart Disease Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Congenital Heart Disease Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Congenital Heart Disease Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Congenital Heart Disease Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Congenital Heart Disease Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Congenital Heart Disease Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Congenital Heart Disease Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Congenital Heart Disease Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Congenital Heart Disease Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Congenital Heart Disease Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Congenital Heart Disease Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Congenital Heart Disease Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Congenital Heart Disease Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Congenital Heart Disease Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Congenital Heart Disease Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Congenital Heart Disease Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Congenital Heart Disease Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Congenital Heart Disease Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Congenital Heart Disease Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Congenital Heart Disease Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Congenital Heart Disease Product
Table 64. Pfizer Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Congenital Heart Disease Product
Table 69. Novartis Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Abbott Laboratories Company Details
Table 72. Abbott Laboratories Business Overview
Table 73. Abbott Laboratories Congenital Heart Disease Product
Table 74. Abbott Laboratories Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 75. Abbott Laboratories Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Congenital Heart Disease Product
Table 79. Roche Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 80. Roche Recent Development
Table 81. GSK Company Details
Table 82. GSK Business Overview
Table 83. GSK Congenital Heart Disease Product
Table 84. GSK Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 85. GSK Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Congenital Heart Disease Product
Table 89. Sanofi Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Congenital Heart Disease Product
Table 94. Johnson & Johnson Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Medtronic Company Details
Table 97. Medtronic Business Overview
Table 98. Medtronic Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 99. Medtronic Recent Development
Table 100. BD Company Details
Table 101. BD Business Overview
Table 102. BD Congenital Heart Disease Product
Table 103. BD Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 104. BD Recent Development
Table 105. Boston Scientific Company Details
Table 106. Boston Scientific Business Overview
Table 107. Boston Scientific Congenital Heart Disease Product
Table 108. Boston Scientific Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 109. Boston Scientific Recent Development
Table 110. Merck Company Details
Table 111. Merck Business Overview
Table 112. Merck Congenital Heart Disease Product
Table 113. Merck Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 114. Merck Recent Development
Table 115. Eli Lilly Company Details
Table 116. Eli Lilly Business Overview
Table 117. Eli Lilly Congenital Heart Disease Product
Table 118. Eli Lilly Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 119. Eli Lilly Recent Development
Table 120. Mylan Company Details
Table 121. Mylan Business Overview
Table 122. Mylan Congenital Heart Disease Product
Table 123. Mylan Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 124. Mylan Recent Development
Table 125. Sun Pharmaceutical Company Details
Table 126. Sun Pharmaceutical Business Overview
Table 127. Sun Pharmaceutical Congenital Heart Disease Product
Table 128. Sun Pharmaceutical Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 129. Sun Pharmaceutical Recent Development
Table 130. AstraZeneca Company Details
Table 131. AstraZeneca Business Overview
Table 132. AstraZeneca Congenital Heart Disease Product
Table 133. AstraZeneca Revenue in Congenital Heart Disease Business (2016-2021) & (US$ Million)
Table 134. AstraZeneca Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Congenital Heart Disease Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Surgical Therapy Features
Figure 4. Global Congenital Heart Disease Market Share by Application: 2020 VS 2027
Figure 5. Hospitals and clinics Case Studies
Figure 6. Diagnostic centres Case Studies
Figure 7. Congenital Heart Disease Report Years Considered
Figure 8. Global Congenital Heart Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Congenital Heart Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Congenital Heart Disease Market Share by Regions: 2020 VS 2027
Figure 11. Global Congenital Heart Disease Market Share by Regions (2022-2027)
Figure 12. Global Congenital Heart Disease Market Share by Players in 2020
Figure 13. Global Top Congenital Heart Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congenital Heart Disease as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Congenital Heart Disease Revenue in 2020
Figure 15. Global Congenital Heart Disease Revenue Market Share by Type (2016-2021)
Figure 16. Global Congenital Heart Disease Revenue Market Share by Type (2022-2027)
Figure 17. North America Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Congenital Heart Disease Market Share by Type (2016-2027)
Figure 19. North America Congenital Heart Disease Market Share by Application (2016-2027)
Figure 20. North America Congenital Heart Disease Market Share by Country (2016-2027)
Figure 21. United States Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Congenital Heart Disease Market Share by Type (2016-2027)
Figure 25. Europe Congenital Heart Disease Market Share by Application (2016-2027)
Figure 26. Europe Congenital Heart Disease Market Share by Country (2016-2027)
Figure 27. Germany Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Congenital Heart Disease Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Congenital Heart Disease Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Congenital Heart Disease Market Share by Region (2016-2027)
Figure 37. China Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Congenital Heart Disease Market Share by Type (2016-2027)
Figure 45. Latin America Congenital Heart Disease Market Share by Application (2016-2027)
Figure 46. Latin America Congenital Heart Disease Market Share by Country (2016-2027)
Figure 47. Mexico Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Congenital Heart Disease Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Congenital Heart Disease Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Congenital Heart Disease Market Share by Country (2016-2027)
Figure 53. Turkey Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Congenital Heart Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 57. Novartis Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 58. Abbott Laboratories Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 60. GSK Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 63. Medtronic Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 64. BD Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 65. Boston Scientific Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 68. Mylan Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 69. Sun Pharmaceutical Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 70. AstraZeneca Revenue Growth Rate in Congenital Heart Disease Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の先天性心疾患市場規模・現状・予測（2021年-2027年）

Global Congenital Heart Diseases Market Size, Status and Forecast 2021-2027
QYR2104Z1538 2021年4月 95Pages
QYResearch社発行の本調査資料では、先天性心疾患のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（低形成、閉塞性、中隔欠損症）、用途別市場規模（病院、外来手術センター、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の炎症性心臓病市場規模・現状・予測（2021年-2027年）

Global Inflammatory Heart Disease Market Size, Status and Forecast 2021-2027
QYR2104Z3163 2021年4月 98Pages
QYResearch社発行の本調査資料では、炎症性心臓病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アテローム性動脈硬化症、心筋炎、心膜炎）、用途別市場規模（病院・診断センター、外来サービスセンター）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のリウマチ性心臓病市場規模・現状・予測（2021年-2027年）

Global Rheumatic Heart Disease Market Size, Status and Forecast 2021-2027
QYR2104Z6194 2021年4月 131Pages
QYResearch社発行の本調査資料では、リウマチ性心臓病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（心筋炎、心膜炎）、用途別市場規模（病院、診断センター、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の心不全遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy For Heart Failure Market Size, Status and Forecast 2021-2027
QYR2104Z2519 2021年4月 94Pages
QYResearch社発行の本調査資料では、心不全遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子組み換え、遺伝子置換、その他）、用途別市場規模（病院、実験室、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の心臓健康製品市場規模・現状・予測（2021年-2027年）

Global Heart Health Products Market Size, Status and Forecast 2021-2027
QYR2104Z2744 2021年4月 93Pages
QYResearch社発行の本調査資料では、心臓健康製品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（穀物・豆類、果物、野菜）、用途別市場規模（子供、大人）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東...

世界の心臓発作診断市場規模・現状・予測（2021年-2027年）

Global Heart Attack Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z2742 2021年4月 92Pages
QYResearch社発行の本調査資料では、心臓発作診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（心電図、血液検査、心エコー図）、用途別市場規模（病院・クリニック、個人用、健康診断）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の心臓健康成分市場規模・現状・予測（2021年-2027年）

Global Heart Health Ingredients Market Size, Status and Forecast 2021-2027
QYR2104Z2743 2021年4月 97Pages
QYResearch社発行の本調査資料では、心臓健康成分のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オメガ3、ベータグルカン、フィトステロール、大豆たんぱく質、その他）、用途別市場規模（医薬品、サプリメント、飲料、乳製品・冷凍デザート、甘味...

世界のベーチェット病市場規模・現状・予測（2021年-2027年）

Global Behcets Disease Market Size, Status and Forecast 2021-2027
QYR2104Z0739 2021年4月 91Pages
QYResearch社発行の本調査資料では、ベーチェット病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤、免疫調節剤）、用途別市場規模（目、腸、皮膚、粘膜、肺、脳、骨、血管、心臓）、主要地域別市場規模（北米、アメ...

世界の心臓弁修復・交換市場規模・現状・予測（2021年-2027年）

Global Heart Valve Repair and Replacement Market Size, Status and Forecast 2021-2027
QYR2104Z2747 2021年4月 90Pages
QYResearch社発行の本調査資料では、心臓弁修復・交換のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経カテーテル大動脈弁置換術（TAVR）、経カテーテル僧帽弁修復術（TMVR））、用途別市場規模（病院、外来手術センター、心臓カテーテル検...

世界の急性心不全（AHF）治療市場規模・現状・予測（2021年-2027年）

Global Acute Heart Failure (AHF) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0056 2021年4月 95Pages
QYResearch社発行の本調査資料では、急性心不全（AHF）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B遮断薬、カルシウムチャネル遮断薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）、用途別市場規模（病院、クリニック...

世界の先天性心疾患市場規模・現状・予測（2021年-2027年） Congenital diseases are disorders in a newborn due to certain genetic factors (and sometimes in association with the environment) that often results in malformations or underdeveloped organs. Congenital Heart Diseases (CHD) results in malformed or undeveloped heart that presents in a newborn with br…
世界の炎症性心臓病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Inflammatory Heart Disease Market The global Inflammatory Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
世界のリウマチ性心臓病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Rheumatic Heart Disease Market The global Rheumatic Heart Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
世界の心不全遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy provides a novel strategy for targeting abnormalities in heart cells that adversely affect heart function. Market Analysis and Insights: Global Gene Therapy For Heart Failure Market The global Gene Therapy For Heart Failure market size is projected to reach US$ XX million by 2027, from …
世界のメニエール病治療薬市場規模・現状・予測（2021年-2027年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…